Article metrics

PDF

Extended report
Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study

Statistics from Altmetric.com

Online download statistics by month:

AbstractFullPDF
Aug 201713411344436
Total13411344436